Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox and fractional CO2 laser for prevention of fresh facial scar formation
TCTR20241002006Phase 3Recruiting
- Sponsor
- Damascus University
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in severe cutaneous adverse reactions (SCAR), sponsored by Damascus University. Started Jul 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
severe cutaneous adverse reactions (SCAR)
Beyond the preview
Go deeper on TCTR20241002006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241002006.